Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-41 passage
• An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis1 passage
• Asthma and COVID-19 risk: a systematic review and meta-analysis1 passage
• Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis1 passage
• European Respiratory Society and American Thoracic Society guidelines for the diagnosis of primary ciliary dyskinesia1 passage
• European Respiratory Society clinical practice guideline for the management of adult bronchiectasis1 passage
• European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis1 passage
• Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results1 passage
• Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline1 passage
• Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline1 passage